Compile Data Set for Download or QSAR
maximum 50k data
Found 1073 with Last Name = 'wrona' and Initial = 'i'
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483007(US10919885, Compound No. 156)
Affinity DataIC50:  10nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483029(US10919885, Compound No. 178)
Affinity DataIC50:  10nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483044(US10919885, Compound No. 193)
Affinity DataIC50:  10nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482888(US10919885, Compound No. 36)
Affinity DataIC50:  10nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482882(US10919885, Compound No. 30)
Affinity DataIC50:  10nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482937(US10919885, Compound No. 85)
Affinity DataIC50:  11nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483036(US10919885, Compound No. 185)
Affinity DataIC50:  12nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482910(US10919885, Compound No. 58)
Affinity DataIC50:  20nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482874(US10919885, Compound No. 22)
Affinity DataIC50:  20nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483054(US10919885, Compound No. 203)
Affinity DataIC50:  25nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482969(US10919885, Compound No. 117)
Affinity DataIC50:  26nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482858(US10919885, Compound No. 6)
Affinity DataIC50:  30nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482912(US10919885, Compound No. 60)
Affinity DataIC50:  30nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482882(US10919885, Compound No. 30)
Affinity DataIC50:  30nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482863(US10919885, Compound No. 11)
Affinity DataIC50:  30nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482954(US10919885, Compound No. 102)
Affinity DataIC50:  36nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482866(US10919885, Compound No. 14)
Affinity DataIC50:  40nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483044(US10919885, Compound No. 193)
Affinity DataIC50:  47nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482958(US10919885, Compound No. 106)
Affinity DataIC50:  48nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483029(US10919885, Compound No. 178)
Affinity DataIC50:  50nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482863(US10919885, Compound No. 11)
Affinity DataIC50:  50nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483036(US10919885, Compound No. 185)
Affinity DataIC50:  52nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483010(US10919885, Compound No. 159)
Affinity DataIC50:  58nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482943(US10919885, Compound No. 91)
Affinity DataIC50:  58nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483040(US10919885, Compound No. 189)
Affinity DataIC50:  65nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482935(US10919885, Compound No. 83)
Affinity DataIC50:  66nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482956(US10919885, Compound No. 104)
Affinity DataIC50:  66nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482905(US10919885, Compound No. 53)
Affinity DataIC50:  70nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482856(US10919885, Compound No. 4)
Affinity DataIC50:  70nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482954(US10919885, Compound No. 102)
Affinity DataIC50:  73nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483039(US10919885, Compound No. 188)
Affinity DataIC50:  74nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482875(US10919885, Compound No. 23)
Affinity DataIC50:  80nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM63417(MLS000730236 | N-[1-(4-fluorobenzyl)-1H-pyrazol-4-...)
Affinity DataIC50:  80nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482924(US10919885, Compound No. 72)
Affinity DataIC50:  84nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483156(US10919885, Compound No. 305)
Affinity DataIC50:  90nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482859(US10919885, Compound No. 7)
Affinity DataIC50:  90nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM483155(US10919885, Compound No. 304)
Affinity DataIC50:  90nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase 5(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482880(US10919885, Compound No. 28)
Affinity DataIC50:  90nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStearoyl-CoA desaturase(Homo sapiens (Human))
Yumanity Therapeutics

US Patent
LigandPNGBDBM482856(US10919885, Compound No. 4)
Affinity DataIC50:  90nMAssay Description:Strains expressing SCD1 or SCD5 as the sole desaturase, the human SCD1 and SCD5 genes were used to evaluate inhibition of SCD1/SCD5 using reduced gro...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628785(US20230339890, Compound 35 | US20230339890, Compou...)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628868(US20230339890, Compound 23)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628792(US20230339890, Compound 11)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628788(US20230339890, Compound 109)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628776(US20230339890, Compound 131)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628775(US20230339890, Compound 107)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628771(US20230339890, Compound 8)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628770(US20230339890, Compound 130)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628763(Preparation of N-[(2S)-2-Hydroxy-2-(3-Pyridyl)Ethy...)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628761(US20230339890, Compound 105)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLanosterol 14-alpha demethylase(Homo sapiens (Human))
Kineta

US Patent
LigandPNGBDBM628757(US20230339890, Compound 31)
Affinity DataIC50: <100nMAssay Description:Method: Recombinant human CYP51A1 (lanosterol-14a-demethylase) enzyme was coexpressed with CYP reductase in bacterial membranes and the fluorescent s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1073 total ) | Next | Last >>
Jump to: